| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |